HBM BioVentures

de

HBM BioVentures Ltd

Cayman Subsidiary

Investment Manager

Investment Advisor Europe

Investment Advisor USA

HBM BioVentures (Cayman) Ltd

Centennial Towers, 3rd Floor
2454 West Bay Road
Grand Cayman, Cayman Islands

Phone	+1 345 946 8002
Fax	+1 345 946 8003

Contact	John Arnold, Managing Director
Email	arnold@hbmcayman.com

News

Press Releases
»	HBM BioVentures Quarterly Report as at 30 June 2010
»	HBM BioVentures’ largest public investment – Micrus – acquired by Johnson & Johnson
»	HBM BioVentures sells USD hedging position at a profit
»	Shareholders’ meeting approves all proposals by Board of Directors by large majority; Hans Peter Hasler appointed as new Chairman of the Board of Directors; Astellas, which recently acquired OSI Pharmaceuticals, will retain HBM BioVentures shares and intensify cooperation
»	Archive

Financial Reports

»	Quarterly Report June 2010
»	Annual Report 2009/2010
»	Archive

Share Price

SIX Swiss Exchange Ticker
HBMN

Key Figures

as at 31.8.2010	CHF

NAV per share	62.58
Net assets	616 Mio.

Search

News Registration